Walking While Talking and Prefrontal Oxygenation in Motoric Cognitive Risk Syndrome: Clinical and Pathophysiological Aspects.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2021
Historique:
pubmed: 9 11 2021
medline: 21 1 2022
entrez: 8 11 2021
Statut: ppublish

Résumé

Motoric cognitive risk syndrome (MCR) combines slow gait and cognitive complaints and has been proposed as a predementia syndrome. The nature of dual-task performance in MCR has not been established. To assess differences in dual-task performance between participants with and without MCR and to study the prefrontal cortex (PFC)-based brain activity during dual-task using functional near-infrared spectroscopy. Cohort study of community-dwelling non-demented older adults included in the "Central Control of Mobility in Aging" study. Comprehensive assessment included global cognition and executive function tests along with clinical variables. Dual-task paradigm consisted in walking while reciting alternate letters of the alphabet (WWT) on an electronic walkway. We compared dual-task performance between MCR (n = 60) and No MCR (n = 478) participants and assessed the relationship of dual-task performance with cognitive function. In a subsample, we compared PFC oxygenation during WWT between MCR (n = 32) and No MCR (n = 293). In our sample of 538 high-functioning older adults (76.6±6.5 years), with 11.2% prevalence of MCR, dual-task cost was not significantly different, compared to No MCR participants. Among MCR participants, no significant relationship was found between WWT velocity and cognitive function, whereas No MCR participants with better cognitive function showed faster WWT velocities. PFC oxygenation during WWT was higher in MCR compared to No MCR (1.02±1.25 versus 0.66±0.83, p = 0.03). MCR participants showed no significant differences in the dual-task cost while exhibiting higher PFC oxygenation during dual-task walking. The dual-task performance (WWT velocity) in MCR participants was not related to cognition.

Sections du résumé

BACKGROUND
Motoric cognitive risk syndrome (MCR) combines slow gait and cognitive complaints and has been proposed as a predementia syndrome. The nature of dual-task performance in MCR has not been established.
OBJECTIVE
To assess differences in dual-task performance between participants with and without MCR and to study the prefrontal cortex (PFC)-based brain activity during dual-task using functional near-infrared spectroscopy.
METHODS
Cohort study of community-dwelling non-demented older adults included in the "Central Control of Mobility in Aging" study. Comprehensive assessment included global cognition and executive function tests along with clinical variables. Dual-task paradigm consisted in walking while reciting alternate letters of the alphabet (WWT) on an electronic walkway. We compared dual-task performance between MCR (n = 60) and No MCR (n = 478) participants and assessed the relationship of dual-task performance with cognitive function. In a subsample, we compared PFC oxygenation during WWT between MCR (n = 32) and No MCR (n = 293).
RESULTS
In our sample of 538 high-functioning older adults (76.6±6.5 years), with 11.2% prevalence of MCR, dual-task cost was not significantly different, compared to No MCR participants. Among MCR participants, no significant relationship was found between WWT velocity and cognitive function, whereas No MCR participants with better cognitive function showed faster WWT velocities. PFC oxygenation during WWT was higher in MCR compared to No MCR (1.02±1.25 versus 0.66±0.83, p = 0.03).
CONCLUSION
MCR participants showed no significant differences in the dual-task cost while exhibiting higher PFC oxygenation during dual-task walking. The dual-task performance (WWT velocity) in MCR participants was not related to cognition.

Identifiants

pubmed: 34744077
pii: JAD210239
doi: 10.3233/JAD-210239
pmc: PMC8784921
mid: NIHMS1770613
doi:

Substances chimiques

Oxygen S88TT14065

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1585-1596

Subventions

Organisme : NIA NIH HHS
ID : R01 AG036921
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG044007
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG057548
Pays : United States

Références

J Gerontol A Biol Sci Med Sci. 2009 Aug;64(8):896-901
pubmed: 19349593
Neuroimage. 2015 May 15;112:152-159
pubmed: 25765257
Rep Prog Phys. 2010 Jul;73(7):
pubmed: 26120204
J Alzheimers Dis. 2017;59(1):77-84
pubmed: 28582865
Gait Posture. 2012 Jan;35(1):96-100
pubmed: 21940172
Hum Brain Mapp. 2014 Aug;35(8):4090-104
pubmed: 24522972
Mov Disord. 2008 Feb 15;23(3):329-42; quiz 472
pubmed: 18058946
Gait Posture. 2007 Oct;26(4):572-6
pubmed: 17344044
N Engl J Med. 2011 Jun 9;364(23):2227-34
pubmed: 21651394
Exp Brain Res. 2009 Mar;193(3):445-54
pubmed: 19030850
J Alzheimers Dis. 2016 Jun 18;53(3):1043-52
pubmed: 27340851
Alzheimers Dement. 2016 May;12(5):556-64
pubmed: 26545790
J Gerontol A Biol Sci Med Sci. 2008 Dec;63(12):1335-43
pubmed: 19126846
J Int Neuropsychol Soc. 2009 May;15(3):438-50
pubmed: 19402930
J Alzheimers Dis. 2019;71(s1):S95-S103
pubmed: 30909242
Gait Posture. 2017 Oct;58:130-135
pubmed: 28778021
J Gerontol A Biol Sci Med Sci. 2016 Aug;71(8):1081-8
pubmed: 26946101
Arch Phys Med Rehabil. 2007 Jan;88(1):50-3
pubmed: 17207675
Brain Res Cogn Brain Res. 2005 Jul;24(2):237-51
pubmed: 15993762
J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):929-35
pubmed: 17237140
Neurodegener Dis Manag. 2014;4(5):339-42
pubmed: 25405646
Age Ageing. 2006 Nov;35(6):619-24
pubmed: 17047008
Neurosci Biobehav Rev. 2011 Jan;35(3):715-28
pubmed: 20833198
Aging Ment Health. 2021 Sep;25(9):1618-1629
pubmed: 32757759
Aging Clin Exp Res. 2013 Oct;25(5):539-44
pubmed: 23949972
J Gerontol A Biol Sci Med Sci. 2013 Apr;68(4):412-8
pubmed: 22987797
Biomed Eng Online. 2010 Mar 09;9:16
pubmed: 20214809
JAMA. 2004 Nov 3;292(17):2115-24
pubmed: 15523072
J Gerontol A Biol Sci Med Sci. 2019 May 16;74(6):884-889
pubmed: 29985983
Neurology. 2005 Aug 23;65(4):559-64
pubmed: 16116116
J Clin Psychiatry. 2017 May;78(5):e529-e536
pubmed: 28406265
BMC Geriatr. 2009 Sep 01;9:41
pubmed: 19723315
J Gerontol A Biol Sci Med Sci. 2011 Aug;66(8):879-87
pubmed: 21593013
J Am Geriatr Soc. 2003 Nov;51(11):1633-7
pubmed: 14687395
Brain Topogr. 2016 Mar;29(2):334-43
pubmed: 26613725
Cortex. 2013 Nov-Dec;49(10):2845-52
pubmed: 24079917
J Neurol Sci. 2006 Oct 25;248(1-2):196-204
pubmed: 16806270
Hum Brain Mapp. 2015 Apr;36(4):1484-93
pubmed: 25504964
J Clin Exp Neuropsychol. 1998 Jun;20(3):310-9
pubmed: 9845158
Neurology. 2014 Aug 19;83(8):718-26
pubmed: 25031288
Neuron. 2006 Dec 21;52(6):1109-20
pubmed: 17178412
N Engl J Med. 2002 Nov 28;347(22):1761-8
pubmed: 12456852
Brain Imaging Behav. 2017 Jun;11(3):887-898
pubmed: 27392792
Neuroscience. 2016 Mar 11;317:36-46
pubmed: 26762801
Neuropsychol Rev. 2006 Mar;16(1):17-42
pubmed: 16794878
J Gerontol A Biol Sci Med Sci. 2016 Mar;71(3):378-84
pubmed: 26248559
Alzheimers Dement. 2019 Jul;15(7):870-877
pubmed: 31164315
J Psychiatr Res. 1982-1983;17(1):37-49
pubmed: 7183759
Eur J Neurol. 2017 Aug;24(8):1047-1054
pubmed: 28621495
Handb Clin Neurol. 2018;159:119-134
pubmed: 30482309
JAMA. 2008 Aug 20;300(7):823-30
pubmed: 18714062
J Am Geriatr Soc. 2005 Mar;53(3):410-5
pubmed: 15743282
J Mov Disord. 2017 Jan;10(1):1-17
pubmed: 28122432
Rev Neurosci. 2020 Oct 25;31(7):723-742
pubmed: 32678804
Neurology. 2017 Jan 10;88(2):191-197
pubmed: 27927937
Age (Dordr). 2014 Feb;36(1):373-81
pubmed: 23943111
J Alzheimers Dis. 2019;71(s1):S65-S73
pubmed: 30814353
Conf Proc IEEE Eng Med Biol Soc. 2006;2006:2671-4
pubmed: 17946973
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
BMC Neurol. 2014 Apr 01;14:67
pubmed: 24694100
Neuropsychologia. 2009 Aug;47(10):2015-28
pubmed: 19467352
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4 Suppl 3):S152-69
pubmed: 17135809
Neuropsychology. 2006 Mar;20(2):215-23
pubmed: 16594782

Auteurs

Cristina Udina (C)

REFiT Barcelona Research Group, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Medicine Department, Universitat Autonoma de Barcelona, Barcelona, Spain.

Emmeline Ayers (E)

Albert Einstein College of Medicine, Bronx, NY, USA.

Marco Inzitari (M)

REFiT Barcelona Research Group, Parc Sanitari Pere Virgili and Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
Medicine Department, Universitat Autonoma de Barcelona, Barcelona, Spain.

Joe Verghese (J)

Albert Einstein College of Medicine, Bronx, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH